New Delhi, Jan. 20 -- The healthcare industry believes that Budget 2026 will indicate how the sector is positioned within India's growth priorities amid large patient volumes, uneven capacity, and high dependence on imported medical equipment.

Sudarshan Jain, Secretary General of Indian Pharmaceutical Alliance feels that the pharma sector is faced with global challenges, including Donald Trump's tariffs, supply chain disruptions, and geopolitical uncertainty. All this underscore the need for strategic support to maintain and strengthen India's competitive edge.

Dr Mukesh Batra, Founder-Chairman Emeritus of Dr Batra's Healthcare, stressed on the importance of judicious use of allocated funds, adding, "As we look ahead to Budget 2026-27, ...